Holen Sie sich die Stockscreener-App
3.90
2.36%
0.09
Handel nachbörslich:
3.89
-0.010
-0.26%
Schlusskurs vom Vortag:
$3.81
Offen:
$3.84
24-Stunden-Volumen:
1.23M
Relative Volume:
1.66
Marktkapitalisierung:
$241.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-73.79M
KGV:
-2.1196
EPS:
-1.84
Netto-Cashflow:
$-77.44M
1W Leistung:
+14.71%
1M Leistung:
+51.75%
6M Leistung:
+209.52%
1J Leistung:
+2.63%
1-Tages-Spanne:
$3.60
$4.1691
1-Wochen-Bereich:
$3.28
$4.1691
52-Wochen-Spanne:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Firmenname
Pyxis Oncology Inc
Sektor
Branche
Telefon
(617) 221-9059
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie PYXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
3.90 | 237.23M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | Guggenheim | Buy |
| 2024-11-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-08-08 | Eingeleitet | Stifel | Buy |
| 2024-05-07 | Fortgesetzt | Jefferies | Buy |
| 2024-02-09 | Eingeleitet | BTIG Research | Buy |
| 2024-01-23 | Eingeleitet | Leerink Partners | Outperform |
| 2023-09-05 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-11-02 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
Guggenheim raises Pyxis Oncology stock price target to $7 on expanded trial data By Investing.com - Investing.com South Africa
Guggenheim raises Pyxis Oncology stock price target to $7 on expanded trial data - Investing.com Australia
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated by Analysts at Stifel Nicolaus - MarketBeat
Pyxis Oncology (NASDAQ:PYXS) Issues Quarterly Earnings Results - MarketBeat
Pyxis Oncology And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Can Pyxis Oncology Inc. stock beat analyst upgradesJuly 2025 Spike Watch & Accurate Intraday Trade Tips - newser.com
Custom watchlist performance reports with Pyxis Oncology Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
How to manage a losing position in Pyxis Oncology Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com
Ranking Pyxis Oncology Inc. among high performing stocks via tools2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Signal strength of Pyxis Oncology Inc. stock in tech scanners2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Is Pyxis Oncology Inc. stock bottoming outWall Street Watch & Daily Profit Focused Screening - newser.com
Is Pyxis Oncology Inc. stock gaining market sharePortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
How risky is Pyxis Oncology Inc. stock nowEntry Point & Weekly High Potential Alerts - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth fundsMarket Rally & Free Community Supported Trade Ideas - newser.com
Pyxis Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Kroger (NYSE: KR) names George Vincent general counsel; Christine Wheatley retiring Sep. 1 - Stock Titan
Pyxis Oncology Inc Stock Analysis and ForecastMarket Profile Overview & Multiply Your Assets With Time-Tested Picks - earlytimes.in
What analyst consensus says on Pyxis Oncology Inc. stockTrade Performance Summary & Precise Swing Trade Alerts - newser.com
How Pyxis Oncology Inc. stock reacts to global recession fearsMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Backtesting results for Pyxis Oncology Inc. trading strategiesM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
Applying Elliott Wave Theory to Pyxis Oncology Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Pyxis Oncology Keeps Losses Steady As It Eyes Key Trial Data - Finimize
Will Pyxis Oncology Inc. stock split again soon2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Is Pyxis Oncology Inc. stock cheap at current valuationJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Why Pyxis Oncology Inc. stock remains undervaluedRecession Risk & High Return Stock Watch Alerts - newser.com
Will Pyxis Oncology Inc. stock continue upward momentumJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Pyxis Oncology, Inc. SEC 10-Q Report - TradingView
[10-Q] Pyxis Oncology, Inc. Quarterly Earnings Report | PYXS SEC FilingForm 10-Q - Stock Titan
[8-K] Pyxis Oncology, Inc. Reports Material Event | PYXS SEC FilingForm 8-K - Stock Titan
Tick level data insight on Pyxis Oncology Inc. volatility2025 Sector Review & Precise Swing Trade Alerts - newser.com
Pyxis Oncology reports Q3 net loss of $22 mln - MarketScreener
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewswire
Published on: 2025-11-03 05:42:22 - newser.com
Will Pyxis Oncology Inc. stock benefit from AI adoptionMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Using flow based indicators on Pyxis Oncology Inc.Market Trend Review & Fast Exit Strategy with Risk Control - newser.com
Is Pyxis Oncology Inc. stock a bargain at current levelsTrade Entry Report & AI Forecasted Stock Moves - newser.com
Will Pyxis Oncology Inc. stock deliver better than expected guidance2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
Why Pyxis Oncology Inc. stock is a value investor pickTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
When is the best time to exit Pyxis Oncology Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):